Tumour infiltrating lymphocytes (TILs), PD-L1 expression and their dynamics in the NeoTRIPaPDL1 trial

ANNALS OF ONCOLOGY

ELSEVIER

1. Associazione Italiana per la Ricerca sul Cancro (AIR) [21787]
2. Breast Cancer Research Foundation
3. Roche
4. Celgene